Humacyte Inc

Humacyte Inc

HUMA

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.13B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Humacyte IncHumacyte Inc-1.1--689%-5.7
$-0.11

Current Fair Value

115.3% downside

Overvalued by 115.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.13 Billion
Enterprise Value$1.15 Billion
Dividend Yield$- (-)
Earnings per Share$-0.26
Beta2.52
Outstanding Shares197,846,786

Return

Return on Equity-688.93%ROE
Return on Assets-72.43%
Return on Invested Capital-96.73%

Valuation & Multiples

P/E Ratio-1.11P/E Ratio
PEG0.76PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue569.21
Enterprise Value to EBIT-12.57
Enterprise Value to Net Income-15
Total Debt to Enterprise0.06
Debt to Equity5.67Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 13, 2026
EPS Estimate
$-0.10
Average shareholder expectation
Revenue Estimate
$1.46 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 10, 2026
EPS Estimate
$-0.10
Average shareholder expectation
Revenue Estimate
$1.12 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000 42.01%
Total Calls- 100.00%
Total Puts- 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %1.15% 28.68%
Total Invested$1.77M 95.08%
Investors Holding43 122.00%

ESG Score

No data

About Alpha Healthcare Acquisition Corp.

CEO: Mr. Rajiv Sarman Shukla

Alpha Healthcare Acquisition Corp. is a blank check company. The company was incorporated in 2020 and is based in New York, New York.